You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Bulk Pharmaceutical API Sources for DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free H8502_SIGMA ⤷  Get Started Free
Ambinter ⤷  Get Started Free BB_NC-1356 ⤷  Get Started Free
Calbiochem ⤷  Get Started Free 4000 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: Dopamine Hydrochloride and Dextrose 5%

Last updated: August 7, 2025


Introduction

In the pharmaceutical supply chain, the sourcing of Active Pharmaceutical Ingredients (APIs)—notably Dopamine Hydrochloride and Dextrose 5%—is critical for ensuring drug efficacy, safety, and regulatory compliance. These compounds serve essential roles in cardiovascular support and energy/nutrition therapy, respectively. Their procurement involves navigating a landscape of reputable manufacturers, regulatory standards, and global logistics to maintain consistent, high-quality supply.

This article provides a detailed analysis of reliable sources for bulk Dopamine Hydrochloride and Dextrose 5%, exploring manufacturer capabilities, geographical regions, regulatory considerations, and market trends vital for pharmaceutical procurement strategies.


Dopamine Hydrochloride API: Overview and Global Supply

Chemical Profile

Dopamine Hydrochloride is a vasopressor and inotropic agent used for shock, heart failure, and hypotension. Its chemical stability, purity, and bioavailability hinge on sourcing from reputable manufacturers adhering to Good Manufacturing Practices (GMP).

Key Characteristics for Sourcing

  • Quality Assurance: GMP compliance, USP/NF or EP quality standards.
  • Certifications: Certificates of Analysis (CoA), Certificates of Good Manufacturing Practice (cGMP).
  • Pricing & Lead Time: Competitive, with consistent supply capabilities.
  • Regulatory Approvals: Access to regulatory agency certifications like FDA, EMA, and WHO prequalification.

Major Manufacturers and Suppliers of Dopamine Hydrochloride

  1. Siegfried AG (Germany)
    Known for its high-quality pharmaceutical ingredients and excipients, Siegfried supplies Dopamine Hydrochloride suitable for injectable formulations. Their GMP-certified facilities and comprehensive documentation support global distribution.

  2. Yunnan Baiyao Group Co., Ltd. (China)
    A significant Chinese manufacturer that offers GMP-compliant Dopamine Hydrochloride suitable for export. Their products undergo rigorous quality testing aligned with international standards.

  3. Suzhou Chemspec Fine Chemical Co., Ltd. (China)
    Specializes in bulk APIs, including Dopamine Hydrochloride, with certifications meeting USP and EP standards. They are recognized for reliable supply at competitive prices.

  4. Fresenius Kabi (Germany/India)
    A global leader in injectable APIs, offering Dopamine Hydrochloride with stringent quality controls and extensive regulatory adherence.

  5. SK Chem (South Korea)
    Supplies USP-grade Dopamine Hydrochloride to global markets, emphasizing high purity and regulatory compliance.

Regional Landscape and Supply Chain Dynamics

  • China & India: Dominant manufacturing hubs for affordable APIs, with numerous GMP-compliant suppliers.
  • Europe & North America: Focused on high-quality, regulatory-approved APIs, often at a premium.

Regulatory and Quality Considerations

  • Prefer suppliers with WHO prequalification and FDA approval for ease of registration.
  • Ensure a thorough review of the cofidentiality agreement for proprietary formulations and third-party audits before engagement.

Dextrose 5% API (Dextrose Monohydrate): Overview and Supply

Chemical Profile

Dextrose 5%, also known as Dextrose Monohydrate, is widely used as an intravenous carbohydrate source for nutrition therapy, particularly in hospital settings and neonatal care.

Key Attributes for Procurement

  • Standardization: USP, EP, or BP monographs.
  • Formulation Compatibility: Suitable for injection and high purity.
  • Packaging: Bulk tanks, sterile bags, or drums.
  • Shelf Life and Stability: Proper storage for sustained usability.

Major API Manufacturers and Suppliers of Dextrose 5%

  1. Tate & Lyle PLC (UK)
    Recognized globally for high-grade glucose syrups and Dextrose APIs, offering certified GMP products compatible with pharmaceutical standards.

  2. Jubilant Life Sciences (India)
    Offers pharmaceutical-grade Dextrose Monohydrate, complying with USP/EP standards, with extensive distribution channels worldwide.

  3. Cargill (USA)
    Supplies pharmaceutical-grade glucose products, with consistent supply quality and compliance with international standards.

  4. Shandong Sanfeng Group (China)
    A major producer of dextrose products with GMP certifications, serving both bulk and finished dosage forms.

  5. Roquette Frères (France)
    A leading provider of pharmaceutical-grade glucose and dextrose, emphasizing purity and regulatory compliance for injectable uses.

Supply Chain Considerations

  • Regional Production Hubs: China, India, and the US dominate manufacturing.
  • Global Certification Status: Ensure suppliers adhere to GMP, ISO, and relevant pharmacopeial standards.
  • Logistics & Delivery: Establish agreements for timely supply, considering global transport disruptions.

Market Trends and Considerations

Increasing Demand & Supply Chain Resilience

The COVID-19 pandemic underscored vulnerabilities in global API supply chains, leading to an intensified focus on diversifying sources and maintaining buffer stock. Both Dopamine Hydrochloride and Dextrose 5% have witnessed increased demand amid critical care scenarios.

Regulatory Compliance & Quality Assurance

Tightening regulatory scrutiny mandates rigorous supplier qualification and batch validation. Manufacturers with prequalified status from WHO, FDA, and EMA are prioritized.

Cost Considerations vs. Quality

While India and China offer cost advantages, escalating quality requirements and regulatory compliance heighten the need for due diligence in supplier vetting.


Conclusion

Securing reliable bulk sources for Dopamine Hydrochloride and Dextrose 5% necessitates a strategic approach rooted in quality, regulatory compliance, and supply chain resilience. Leading global manufacturers such as Siegfried, Jubilant, Tate & Lyle, and Cargill stand out as dependable suppliers. Engaging with certified GMP-compliant sources minimizes risks and supports regulatory approval processes.


Key Takeaways

  • Prioritize GMP-certified suppliers with regulatory approvals like USP, EP, or WHO prequalification for both Dopamine Hydrochloride and Dextrose 5%.
  • Diversify sourcing regions—balance between Chinese/Indian cost-effective suppliers and European/US high-standard providers.
  • Verify comprehensive documentation including CoA, stability data, and batch release details before procurement.
  • Monitor global supply chain dynamics and develop contingency plans to mitigate disruptions, especially in critical care applications.
  • Engage in thorough supplier audits to ensure compliance with pharmaceutical standards and establish long-term, reliable partnerships.

FAQs

1. What are the key regulatory standards to consider when sourcing Dopamine Hydrochloride and Dextrose 5% APIs?
Regulatory standards such as USP, EP, BP, and WHO prequalification ensure API quality, purity, and suitability for pharmaceutical use. Choosing suppliers compliant with these standards facilitates regulatory approval and international distribution.

2. Which regions offer the most reliable sources for Dopamine Hydrochloride?
Europe (Germany, Switzerland) and North America (USA) are known for high-quality, regulatory-approved Dopamine APIs, though Chinese and Indian manufacturers provide cost-effective alternatives with GMP compliance.

3. How does supplier qualification impact procurement strategies?
Supplier qualification guarantees adherence to quality standards, regulatory compliance, and supply reliability. It reduces risks associated with substandard ingredients, recalls, and regulatory sanctions.

4. Are there emerging markets or new players in the API sourcing landscape for these compounds?
Yes, newer Chinese and Indian manufacturers are expanding capabilities, often offering competitive pricing and certification pathways, although thorough vetting remains essential.

5. How can procurement teams ensure the consistency of API supply amidst global disruptions?
Developing multi-supplier strategies, maintaining safety stocks, engaging in long-term contracts, and establishing strong quality assurance processes help mitigate supply risks.


References

  1. U.S. Pharmacopeia. (2022). USP Monograph for Dextrose.
  2. European Pharmacopoeia. (2022). Dextrose Monohydrate specifications.
  3. WHO Prequalification Programme. (2022). List of prequalified pharmaceutical ingredients.
  4. Siegfried AG. (2023). Product documentation and GMP certification.
  5. Jubilant Life Sciences. (2023). API supply chain and quality reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.